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ABSTRACT  
Of the many possible health challenges posed during extended exploratory missions to space, the 
effects of space radiation on cardiovascular disease and cancer are of particular concern. There are 
unique challenges to estimating those radiation risks; care and appropriate and rigorous methodology 
should be applied when considering small cohorts such as the NASA astronaut population. The objective 
of this work was to determine if there was sufficient evidence for excess risk of cardiovascular disease 
and cancer in early NASA astronaut cohorts. NASA astronauts in selection groups 1-7 were chosen; this 
relatively homogeneous cohort consists of 73 white males, who unlike today’s astronauts, maintained 
similar smoking and drinking habits to the general US population, and have published radiation doses. 
The participants flew in space on missions Mercury through Shuttle and received space radiation doses 
between 0-74.1 mGy. Cause of death information was obtained from the Lifetime Surveillance of 
Astronaut Health (LSAH) program at NASA Johnson Space Center. Mortality was compared with the US 
male population. Trends of mortality with dose were assessed using a logistic model, fitted by maximum 
likelihood. Only 32 (43.84%) of the 73 early astronauts have died. Standard mortality ratios (SMRs) for 
cancer (n=7, SMR=43.4, 95% CI 17.8, 84.9), all circulatory disease (n=7, SMR=33.2, 95% CI 13.7, 65.0), 
and ischemic heart disease (IHD) (n=5, SMR=40.1, 95% CI 13.2, 89.4) were significantly lower than for 
the US white male population. For cerebrovascular disease, the upper confidence interval for SMR 
included 100, indicating it was not significantly different from the US population (n=2, SMR = 77.0, 95% 
CI 9.4, 268.2). The power of the study is low and remains below 10% even when risks 10 times those 
reported in the literature are assumed [1]. Due to small sample size, there is currently insufficient 
statistical power to evaluate space radiation exposure effects on mortality in NASA astronauts. In 
addition to a comprehensive longitudinal study of NASA astronauts, a research strategy of low dose 
epidemiology data integration with cell and animal studies should be utilized for space radiation risk 
assessment in the astronauts.  
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